FactorPad
Build a Better Process

Stock Risk Measures for Alnylam Pharmaceuticals Inc

A quantitative factor review, as of September 30, 2020.
  1. Company Info - Description, identity and sector data.
  2. Share Data - Stock earnings and key dates.
  3. Market Risk - Beta, size, liquidity and momentum measures.
  4. Financial Risk - Earnings and dividends.
by Paul Alan Davis, CFA
Updated: October 01, 2020
See how we arrive at an overall risk score of 34 for ALNY below.

/ factorpad.com / stocks / f98ccn.html


An ad-free and cookie-free webpage by FactorPad


ALNY Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Alnylam Pharmaceuticals Inc. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how ALNY stock compares to 2,000+ US-based stocks, and to peers in the Health Technology sector and Biotechnology industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Company logo Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases. The company was founded by John Kennedy Clarke, Paul R. Schimmel and Phillip A. Sharp on June 14, 2002 and is headquartered in Cambridge, MA.

Identity

Sector and Industry

Share Data

Shares and Float

Earnings and Dividends

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

/ factorpad.com / stocks / f98ccn.html


ALNY stock risk
ALNYLAM PHARMACEUTICALS INC stock beta
ALNY risk report
ALNY f98ccn
ALNY risk analysis
ALNY volatility
ALNYLAM PHARMACEUTICALS INC credit risk
ALNY liquidity risk
ALNY leverage
ALNY valuation
ALNY systematic risk
ALNY specific risk
ALNYLAM PHARMACEUTICALS INC volatility
ALNY analysis
ALNY financial ratio

This is a new resource, spread the word, tell a friend